XTORO Trademark

Trademark Overview

On Friday, April 13, 2018, a trademark application was filed for XTORO with the United States Patent and Trademark Office. The USPTO has given the XTORO trademark a serial number of 87875613. The federal status of this trademark filing is SECTION 8 - ACCEPTED as of Thursday, September 11, 2025. This trademark is owned by Novartis AG. The XTORO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of diseases and disorders of the ear
xtoro

General Information

Serial Number87875613
Word MarkXTORO
Filing DateFriday, April 13, 2018
Status701 - SECTION 8 - ACCEPTED
Status DateThursday, September 11, 2025
Registration Number5611889
Registration DateTuesday, November 20, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 4, 2018

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of diseases and disorders of the ear

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, April 21, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCUROFIN PHARMA GMBH
Party Type32 - New Owner After Registration
Legal Entity Type27 - NOT AVAILABLE
AddressBERLIN 13125
DE
Party NameMERLION GMBH
Party Type31 - New Owner After Registration
Legal Entity Type27 - NOT AVAILABLE
AddressBERLIN 13125
DE
Party NameMERLION PHARMACEUTICALS, PTE., LTD.
Party Type30 - Original Registrant
Legal Entity Type77 - NOT AVAILABLE
AddressN/A 088702
SG
Party NameMERLION PHARMACEUTICALS, PTE., LTD.
Party Type21 - New Owner After Publication
Legal Entity Type77 - NOT AVAILABLE
AddressN/A 088702
SG
Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBasel
CH
Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBasel
CH

Trademark Events

Event DateEvent Description
Tuesday, April 17, 2018NEW APPLICATION ENTERED
Saturday, April 21, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, June 26, 2018ASSIGNED TO EXAMINER
Thursday, July 12, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, July 26, 2018ASSIGNED TO LIE
Tuesday, July 3, 2018NON-FINAL ACTION WRITTEN
Tuesday, July 3, 2018NON-FINAL ACTION E-MAILED
Tuesday, July 3, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, September 4, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, March 1, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Friday, July 27, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, July 27, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, July 28, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 15, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 4, 2018PUBLISHED FOR OPPOSITION
Wednesday, September 5, 2018AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, November 20, 2018REGISTERED-PRINCIPAL REGISTER
Wednesday, June 3, 2020AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, November 20, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, November 14, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, November 14, 2024TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Thursday, November 14, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, November 14, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, November 14, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, November 14, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, November 14, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, August 12, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, April 30, 2025TEAS SECTION 8 RECEIVED
Thursday, September 11, 2025REGISTERED - SEC. 8 (6-YR) ACCEPTED
Thursday, September 11, 2025NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED

Related Keywords

xtoro disorders diseases treatment preparations pharmaceutical